专利检索 ap:("DANA-FARBER CANCER INSTITUTE, INC." OR "THE GENERAL HOSPITAL CORPORATION" OR "PRESIDENT AND FELLOWS OF HARVARD COLLEGE") AND inv:"Neil Connor Payne" 第 1 页

1.

发明公开
TR-FRET BASED ASSAY FOR DETECTION OF ANTIBODIES IN SEROLOGICAL SAMPLES 审中-公开

公开(公告)号：US20230341394A1

公开(公告)日：2023-10-26

申请号：US18020800

申请日：2021-08-16

申请人： DANA-FARBER CANCER INSTITUTE, INC. , THE GENERAL HOSPITAL CORPORATION , PRESIDENT AND FELLOWS OF HARVARD COLLEGE

发明人： Eric Fischer , Radoslaw Nowak , Hong Yue , Daan Overwijn , Ralph Mazitschek , Neil Connor Payne

IPC分类号： G01N33/569 , G01N33/542

CPC分类号： G01N33/56983 , G01N33/542 , G01N2333/165 , G01N2469/20

摘要： The present invention relates to a homogeneous, time resolved, Förster resonance energy transfer (TR-FRET)-based method for detection of SARS-CoV-2, SARS CoV-1, and MERS-CoV antibodies in a patient fluid sample.

2.

发明申请
METHODS AND MATERIALS FOR MODULATING NRF2 PATHWAY 有权

公开(公告)号：US20220395577A1

公开(公告)日：2022-12-15

申请号：US17765667

申请日：2020-10-02

申请人： The General Hospital Corporation , President and Fellows of Harvard College

发明人： Bakhos Tannous , Christian Badr , Ralph Mazitschek , Neil Connor Payne

IPC分类号： A61K47/55 , C07C323/16 , A61K47/54 , A61P35/00

摘要： The present application provides methods and compounds of modulating Nrf2 pathway. Methods for treating cancer and neurodegenerative conditions are also provided.